Abstract: The present invention relates to topical compositions comprising at least one inorganic micropigment and a cetyl phosphate surfactant mixture consisting essentially of mono- and/or dicetyl esters of phosphoric acid or salts thereof and cetylalcohol and inorganic phosphate and heavy metals and water, characterized in that the surfactant mixture contains no organochlorine impurities and has an inorganic phosphate content of less than 0.7 wt.-% and a heavy metal content of less than 12 ppm.
Type:
Grant
Filed:
June 27, 2017
Date of Patent:
July 7, 2020
Assignee:
DSM IP ASSETS B.V.
Inventors:
Cyrille Deshayes, Andre Duesterloh, Anne Janssen, Thomas Rudolph
Abstract: The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.
Type:
Grant
Filed:
December 21, 2018
Date of Patent:
June 16, 2020
Assignee:
Metabolic Technologies, Inc.
Inventors:
John Rathmacher, John Fuller, Jr., Shawn Baier, Steve Nissen, Naji Abumrad
Abstract: A skin smoothing film made from a skin smoothing composition that comprises sodium silicate, polyvalent silicate and water. Moreover, the film may be made from a composition that has a contraction value of from about 30% to about 160%. The film thickness is from about 5 microns to about 50 microns, preferably from about 10 microns to about 40 microns, when applied. The standard deviation of the film over the area covered is less than about 30, preferably less than about 25.
Type:
Grant
Filed:
February 28, 2019
Date of Patent:
June 16, 2020
Assignee:
The Procter & Gamble Company
Inventors:
Amanda Leigh Newman, Nancy Lorincz Leppla, Laurie Ellen Breyfogle, Gordon Gerald Guay, David Edward Wilson, Joseph Michael Zukowski
Abstract: Embodiments of the invention include methods of treating, preventing, and/or reduce the risk or severity of a condition selected from the group consisting of muscle wasting, muscle weakness, cachexia, and a combination thereof in an individual in need thereof. In some embodiments, particular small molecules are employed for treatment, prevention, and/or reduction in the risk of muscle wasting. In at least particular cases, the small molecules are inhibitors of STAT3.
Type:
Grant
Filed:
July 18, 2014
Date of Patent:
June 9, 2020
Assignee:
Baylor College of Medicine
Inventors:
David J. Tweardy, Moses M. Kasembeli, Marvin X. Xu, Thomas Kristian Eckols
Abstract: Lip compositions, in particular lip gloss compositions, capable of forming a multilayer structure after application to lips are provided, as well as methods of applying such compositions to lips.
Abstract: Provided are a metformin hydrochloride osmotic pump tablet and a preparation method therefor. According to the preparation method, a hetero-type stamping-prepared metformin hydrochloride tablet core is used, and a controlled-release coating is wrapped outside the stamped metformin hydrochloride tablet core, such that the metformin hydrochloride osmotic pump tablet is prepared.
Abstract: Disclosed are devices, systems, and methods for producing broad spectrum disinfectants, sanitizers, cleaner and deodorizers using chlorine dioxide compositions, and more particularly, to methods for producing chlorine dioxide compositions having improved long term stability by the proper choice of pH and through the careful choice of other product formula ingredients.
Abstract: The invention provides dosage forms and methods utilizing nicotine to treat symptoms of a neurologic disorder. In some embodiments, the invention provides compositions for treatment of gait and balance problems associated with Parkinson's Disease.
Abstract: Polymeric reagents are provided comprising a moiety of atoms arranged in a specific order, wherein the moiety is positioned between a water-soluble polymer and a reactive group. The polymeric reagents are useful for, among other things, forming polymer-active agent conjugates. Related methods, compositions, preparations, and so forth are also provided.
Type:
Grant
Filed:
January 31, 2018
Date of Patent:
May 12, 2020
Assignee:
Nektar Therapeutics
Inventors:
J. Milton Harris, Antoni Kozlowski, Samuel P. McManus, Michael D. Bentley, Stephen A. Charles
Abstract: A cosmetic composition for the eyes of the present disclosure contains 10.01 to 30% by mass of a silicone series film forming agent and 25 to 70% by mass of a volatile oil component with respect to the total amount of the cosmetic composition for the eyes. The amount of a volatile silicone series oil component is 25% by mass or greater with respect to the total volatile oil component, and the hardness is 30 or greater and 100 or less. The cosmetic composition has superior cosmetic lasting effects and can be utilized as both mascara and eyeliner.
Abstract: The present invention provides immediate release abuse resistant or deterrent formulations such as ingestible dosage form articles suitable for the delivery of one or more medicaments or other active materials.
Type:
Grant
Filed:
October 4, 2018
Date of Patent:
April 28, 2020
Assignee:
Capsugel Belgium NV
Inventors:
Wei Tian, Jenifer Mains, David Robert Sleith
Abstract: An aqueous composition comprising basic aluminium chloride salt of formula Al2(OH)4.4Cl1.6 to Al2(OH)4.9Cl1.1, calcium chloride at a molar level of 0.020 or greater relative to the aluminium present, and glycine at a molar level of 0.050 or greater relative to the aluminium present, characterised in that the molar ratio of aluminium to the sum of the molar amounts of the calcium chloride and glycine is from 3.9:1 to 6.1:1 and in that the molar ratio of glycine to Al is greater than 1.7:10 and the molar ratio of Ca to Al is less than 0.35:10 or the molar ratio of Ca to Al is greater than 0.35:10 and the molar ratio of glycine to Al is less than 1.7:10.
Type:
Grant
Filed:
October 4, 2016
Date of Patent:
April 28, 2020
Assignee:
Conopco, Inc.
Inventors:
Kevin Ronald Franklin, Neil Robert Fletcher
Abstract: The invention pertains to the use of a composition in the manufacture of a product or method for therapeutically improving, promoting, restoring or maintaining recognition and/or working memory in a subject suffering from PKU and/or in a subject suffering from or at increased risk of impaired recognition and/or working memory associated with PKU, said composition comprising therapeutic amounts of: (i) at least one ?-3 polyunsaturated fatty acid (LCPUFA) selected from the group consisting of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and docosapentaenoic acid (DPA); (ii) choline, a choline salt and/or choline ester; and (iii) at least one B vitamin selected from the group consisting of vitamin B6, vitamin B12 and vitamin B9, including functional equivalents thereof, preferably vitamin B6 and/or vitamin B12, and functional equivalents thereof. The invention also pertains to a composition for use in such use or method.
Type:
Grant
Filed:
October 24, 2016
Date of Patent:
April 28, 2020
Assignee:
N.V. NUTRICIA
Inventors:
Mattheus Cornelis De Wilde, Danielle Stefanie Counotte
Abstract: A method for anesthetizing a patient undergoing a cosmetic surgical procedure comprising: providing an antibiotic medication at least from about 12 hours to about 24 hours prior to the cosmetic surgical procedure; providing a first dosage of oxycodone and a first dosage of promethazine to be taken by the patient prior to arrival at a surgical facility where the cosmetic surgical procedure is to occur; and providing a dosage of lorazepam, a dosage of zolpidem, and a dosage of hydroxyzine just prior to the cosmetic surgical procedure, wherein the zolpidem comprises a dosage of AMBIEN. In one embodiment, the method further comprises: preparing an anesthetizing solution comprising lidocaine, epinephrine, and sodium bicarbonate; and infiltrating the anesthetizing solution in a targeted area of the patient. In another embodiment, the method further comprises: providing one or more reversing agents to the patient after the cosmetic surgical procedure.
Abstract: A vitamin supplement composition that includes a complex with enhanced bioavailability having a vitamin B complex, wherein the vitamin B complex includes: (a) a first vitamin, wherein the first vitamin comprises a form of vitamin B6; (b) a second vitamin, wherein the second vitamin comprises a form of vitamin B9; (c) a third vitamin, wherein the third vitamin comprises a form of vitamin B12; and (d) wherein the first vitamin, the second vitamin, and the third vitamin cooperate synergistically to enhance bioavailability of the same. The present invention further includes a method of administering a vitamin supplement composition to an individual having, for example, MTHFR deficiency.
Abstract: The present invention provides a process for preparing enterically-coated lyospheres comprising a therapeutic agent comprising: a.) providing lyospheres comprising the therapeutic agent; b.) coating said lyospheres with an enteric polymer coating composition; and c.) isolating said enterically-coated lyospheres. In other embodiments, the invention provides dosage forms comprising a lyosphere comprising an effective amount of a therapeutic agent and an enteric polymer coating. In some embodiments, the therapeutic agent in the process or dosage form is a polypeptide, a protein, a peptide, a lipopeptide, a glycoprotein, a fusion protein, a protein conjugate, a cytokine, an enzyme, an antibody, an oligonucleotide, a vaccine vector, small molecule, a live virus, an inactivated virus, a virus-like particle, a viral protein subunit, an adjuvant, microbiome, a prebiotic, a probiotic, or an ectobiotic.
Type:
Grant
Filed:
October 11, 2016
Date of Patent:
April 14, 2020
Assignee:
Merck Sharp & Dohme Corp.
Inventors:
Akhilesh Bhambhani, Robert K. Evans, Pranav Gupta, Ronald L. Smith, Donna M. Williams
Abstract: An aqueous composition for making dip-molded comestible hard capsules comprising a film forming capsule base material and one or more colorants each consisting of a hydrophilic coloring foodstuff concentrate.
Type:
Grant
Filed:
December 30, 2016
Date of Patent:
March 31, 2020
Assignee:
Capsugel Belgium NV
Inventors:
Hugues Straub, Stefaan Jaak Vanquickenborne
Abstract: The present invention relates to a pharmaceutical composition comprising a physical mixture of sacubitril sodium and valsartan disodium, wherein the X-ray powder diffraction pattern of valsartan disodium comprises characteristic peaks at the following 2 theta (±0.2) angles: 4.70°, 9.29°, 22.34°, measured using a Cu K? radiation. The invention further relates to the use of said pharmaceutical composition as medicament in the treatment of heart failure.
Type:
Grant
Filed:
July 26, 2018
Date of Patent:
March 17, 2020
Assignee:
SYNTHON B.V.
Inventors:
Bohumil Dymacek, Marta Vivancos Martinez, Luis Nogueiras Nieto, Lisardo Alvarez Fernandez, Rohit Kumar, Jose Velada Calzada, Petr Mitas
Abstract: The present invention relates to non-mercurial preservatives, including antimicrobial polyamide polymers and octenidine, and to methods of use thereof to produce preservative-containing multi-dose formulations. The preservative-containing multi-dose formulations exhibit resistance to one or more contaminating microorganisms, and have advantageous properties with respect to long term stability of biological and small molecule active ingredients.
Type:
Grant
Filed:
April 13, 2017
Date of Patent:
March 10, 2020
Assignees:
Boehringer Ingelheim Animal Health USA Inc., GENZYME CORPORATION
Inventors:
Guillaume Rigaut, Celine Loss-Dunod, Alexis Guy Andre Lucien Parisot, Pradeep K. Dhal